Clinical Trial Update: Biomarkers for Monitoring Dementia Progression

View source ↗

Summary

A recruiting clinical trial is studying biomarkers to monitor progression in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: IRCCS San Raffaele Roma | Conditions: Alzheimer Disease | Status: RECRUITING